Carcinoid tumours of the extrahepatic biliary ducts represent an extremely rare cause of bile duct obstruction. We report a case of obstructive jaundice secondary to carcinoid tumour arising at the hilar confluence. Resection of the primary tumour was done and the patient is doing well on follow-up. This case demonstrated that surgery offers the only potential cure for biliary carcinoid and aggressive surgical therapy should be the preferred treatment in cases of potentially resectable biliary tumours.
What is known about this subject?
Carcinoid tumour of the hilar region is extremely rare; only 14 cases have been published to date.
What new information is offered in this study?
A carcinoid tumour occurring at the hilar region is an extremely rare cause of obstructive jaundice. Surgery offers the best chance of a cure.
What are the implications for research, policy, or practice?
This case advocates surgery as the preferred option for resectable carcinoid Klatskin tumour; however, further studies are needed to establish protocols for treatment in cases of unresectable disease.
Background
Carcinoma of the extrahepatic biliary ducts account for less than 2 per cent of all cancers, and adenocarcinoma is the most common neoplasm arising from the epithelium of the biliary tree accounting for up to 80 per cent of all duct cancers. 1,2 The overall incidence of carcinoid tumours is estimated to be 1 to 2 per 100,000; however, carcinoid tumours of the extrahepatic biliary ducts are exceedingly rare, accounting for only 0.1-0.2 per cent of all carcinoids of the gastrointestinal tract. 3, 4 Bile duct carcinoids occur more commonly in younger patients and more commonly in women. 5 A review of the published literature since the first reported case in 1959 identified 70 cases with carcinoid tumours arising from the biliary tree have been reported, among which 14 cases present with hilar tumours. [6] [7] [8] We report here a case of obstructive biliopathy secondary to carcinoid tumour arising at the hilar confluence.
Case details
A 56-year-old female presented with a 6-month history of right upper abdominal pain and a 1-month history of progressive jaundice with weight loss. Abdominal ultrasound showed post-cholecystectomy status with mild dilatation of intrahepatic biliary radicles (IHBR). Magnetic resonance cholangiopancreaticography (MRCP) revealed a mitotic soft tissue mass in porta obliterating biliary confluence with IHBR dilatation in both lobes suggestive of Klatskin tumour (Figure 1 ). Contrast enhanced computed tomography (CECT) scan suggested a soft tissue mass in the porta hepatis obstructing the common hepatic duct without major vascular involvement. The patient was planned for surgery and resection of the hilar tumour; hepatico-jejunostomy was also accomplished with lymph node dissection in the peri-portal and peri-choledochal area. A white, well-circumscribed firm nodular mass measuring 1.7 x 1.3 x 0.8cm was found at the hilum. Histopathology revealed small round cells arranged in tubules and glands with a rosette-like pattern that was consistent with features of carcinoid tumour (Figure 2 ). Surgical margins were clear and a total of nine lymph nodes were found that were negative for metastases. The tumour cells were argyrophilic and were positive for chromogranin A and serotonin on immunohistochemistry. There was no intra-operative or postoperative complication and the patient was discharged from the hospital six days after the operation. The patient has been on regular follow-up for the last 18 months and is doing well. 
Discussion
Carcinoid tumours arise from enterochromaffin cells, also known as argentaffin or Kulchitsky cells that are thought to arise from embryonic neural crest cells in the gastrointestinal tract and respiratory cells. 3 The term enterochromaffin refers to the ability to stain with potassium chromate, a feature of cells that contain serotonin. These cells are located in the gastrointestinal tract, most commonly the small intestine, appendix, and rectum, or at various sites within the respiratory tract or the pelvic cavity (uterine, cervix, ovary, and testis), the larynx and the breast. [1] [2] [3] [4] [5] [6] [7] [8] [9] A small number of these cells also exists in the biliary tree. 10 Chronic inflammation of the biliary tract causes an increased number of these cells, thus leading to the development of carcinoid tumours.
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The term "carcinoid tumour" has been replaced by the term "well-differentiated endocrine tumour" by Capella et al. in the latest World Health Organization (WHO) classification of tumours. 12 The WHO staging system is based on criteria such as: tumour size, histological differentiation, Ki-67 immunostaining, invasion of adjacent structures, and vascular and perineural invasion. 12 Pilz reported the first case of a carcinoid tumour that unmistakably arose from the extra-hepatic biliary tract, and since then 70 cases have been reported. 13 Biliary neuroendocrine tumours can be hormonally active and many stain positive for somatostatin, serotonin, and gastrin. Most of the reported cases had non-functioning tumours without evidence of systemic endocrine manifestations. Biliary carcinoids tend to be small (1.1 to 5.5cm) and their presenting symptoms like jaundice, biliary colic, abdominal pain, cholangitis, weakness, weight loss, and backache seem to be secondary to either local invasion into surrounding tissues or metastatic spread. 14, 15 Urinary levels of hydroxyindoleacetic acid are elevated in these patients. 16, 17 The most common anatomical locations for extrahepatic carcinoid tumours are common bile duct (58 per cent), perihilar duct (28 per cent), cystic duct (11 per cent), and common hepatic duct (3 per cent). 1 Our patient had a tumour located in the hilar region. These tumours are more common in women than in men, with a female-to-male ratio of 1.6:1. 7 Their incidence peaks in the sixth decade of life. 11 Our patient was a female in her sixth decade.
Differential diagnosis of carcinoid Klatskin tumour includes cholangiocarcinoma, choledocholithiasis, and hilar strictures. MRCP and CECT can help in differentiating stones from tumours; however, carcinoid tumour can only be distinguished from cholangiocarcinoma by histopathology. Appropriate surgical management for this disease includes resection of the biliary tree with negative margins and restoration of continuity by hepatico-enterostomy along with dissection of lymph nodes in the hepato-duodenal ligament (peri-portal and peri-choledochal).
Available data extrapolated from the existing literature suggest that carcinoid tumours of the extra hepatic biliary tree are of low malignant potential and have a favourable overall prognosis following appropriate surgical management. 18 However, these neoplasms tend to metastasise if left untreated. 9 Complete resection of localised tumours, without metastases, results in a five-year survival rate of 60-100 per cent. 19 Radiotherapy offers no benefit and chemotherapy has been used in metastatic disease with few reports to support any definitive conclusions. 20 As our patient was having a localised disease, surgery offered the best possible treatment for her.
